eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
3/2023
vol. 25
 
Share:
Send email
Share:
Original paper

Association of mental health and medication adherence with blood pressure control in primary care patients with hypertension: a cross-sectional study

Hazem A. Sayed Ahmed
1
,
Abdelrahman Elsayed Elbadawy
2
,
Anwar I. Joudeh
3, 4
,
Jaffer Shah
5
,
Nahed Amen Eldahshan
1

  1. Department of Family Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
  2. General Authority for Healthcare, Port Said, Egypt
  3. Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar
  4. Department of Internal Medicine, Faculty of Medicine, University of Jordan, Amman, Jordan
  5. Weill Cornell Medicine, New York, USA
Family Medicine & Primary Care Review 2023; 25(3): 322–330
DOI: https://doi.org/10.5114/fmpcr.2023.130095
Online publish date: 2023/09/30
Article file
- 14 FM&PCR 3 23 - O - Sayed Ahmed - 1335 - Assciation.pdf  [0.50 MB]
Get citation
 
PlumX metrics:
 
1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 2017; 389(10064): 37–55, doi: 10.1016/S0140-6736(16)31919-5.
2. World Health Organization. Global Action Plan for the prevention and control of noncommunicable diseases. Geneva: WHO Publication. 2013 [cited 10.05.2022]. Available from URL: https://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf?sequence =.
3. Ministry of Health and Population [Egypt], World Health Organization. Egypt National Multisectoral Action Plan for Prevention and Control of Noncommunicable Diseases 2018–2022. Cairo: MOHP report. 2017 [cited 10.05.2022]. Available from URL: http://origin.who.int/ncds/governance/policies/Egypt-NCD-MAP-2018-2022.pdf.
4. World Health Organization. WHO STEPS chronic disease risk factor surveillance: Egypt STEPS Survey 2011–2012. WHO. Fact Sheet 6-3C-1. 2012 [cited 10.05.2022]. Available from URL: http://www.who.int/chp/steps/2011-2012_Egypt_FactSheet.pdf.
5. Ministry of Health and Population [Egypt], World Health Organization. Egypt National Multisectoral Action Plan for Prevention and Control of Noncom-municable Diseases 2018–2022. Cairo: MOHP report. 2017 [cited 10.05.2022]. Available from URL: http://origin.who.int/ncds/governance/policies/EgyptNCD-MAP-2018-2022.pdf.
6. Mills KT, Bundy JD, Kelly TN, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation 2016; 134(6): 441–450, doi: 10.1161/CIRCULATIONAHA.115.018912.
7. Geldsetzer P, Manne-Goehler J, Marcus ME, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults. Lancet 2019; 394(10199): 652–662, doi: 10.1016/S0140-6736(19)30955-9.
8. Ministry of Health and Population [Egypt], El-Zanaty and Associates [Egypt], and ICF International. Egypt Health Issues Survey 2015. Cairo, Egypt and Rockville, Maryland, USA: Ministry of Health and Population and ICF International. 2015 [cited 10.05.2022]. Available from URL: https://dhsprogram.com/pubs/pdf/FR313/FR313.pdf.
9. Ahuja R, Ayala C, Tong X, et al. Public Awareness of Health-Related Risks From Uncontrolled Hypertension. Prev Chronic Dis 2018; 15: E40, doi: 10.5888/pcd15.170362.
10. Chang TE, Ritchey MD, Ayala C, et al. Use of strategies to improve antihypertensive medication adherence within United States outpatient health care practices, DocStyles 2015–2016. J Clin Hypertens (Greenwich) 2018; 20(2): 225–232, doi: 10.1111/jch.13188.
11. Abegaz TM, Shehab A, Gebreyohannes EA, et al. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore) 2017; 96(4): e5641, doi: 10.1097/MD.0000000000005641.
12. Nielsen JØ, Shrestha AD, Neupane D, et al. Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects. J Hum Hypertens 2017; 31(1): 14–21, doi: 10.1038/jhh.2016.31.
13. Tilea I, Petra D, Voidazan S, et al. Treatment adherence among adult hypertensive patients: a cross-sectional retrospective study in primary care in Roma-nia. Patient Prefer Adherence 2018; 12: 625–635, doi: 10.2147/PPA.S162965.
14. Hassanein M. Adherence to antihypertensive fixed-dose combination among Egyptian patients presenting with essential hypertension. Egypt Heart J 2020; 72(1): 10, doi: 10.1186/s43044-020-00044-6.
15. Ramli A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence 2012; 6: 613–622, doi: 10.2147/PPA.S34704.
16. Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clin Hypertens 2020; 26: 18, doi: 10.1186/s40885-020-00151-1.
17. Lulebo AM, Mutombo PB, Mapatano MA, et al. Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: a cross-sectional study. BMC Res Notes 2015; 8: 526, doi: 10.1186/s13104-015-1519-8.
18. Demoner MS, Paula Ramos ER, de, Pereira ER. Factors associated with adherence to antihypertensive treatment in a primary care unit. Acta Paul Enferm 2012; 25(1): 27–34, doi: 10.1590/S0103-21002012000800005.
19. Setiadi AP, Febriandini A, Trinanda E, et al. Knowing the gap: medication use, adherence and blood pressure control among patients with hypertension in Indonesian primary care settings. Peer J 2022; 10: e13171, doi: 10.7717/peerj.13171.
20. Li Z, Li Y, Chen L, et al. Prevalence of Depression in Patients with Hypertension: A Systematic Review and Meta-Analysis [published correction appears in Medicine (Baltimore). 2018; 97(22): e11059]. Medicine (Baltimore) 2015; 94(31): e1317, doi: 10.1097/MD.0000000000001317.
21. Li H, Xia H, Yi S, et al. Social capital, depressive symptoms, and perceived quality of care among hypertensive patients in primary care. Health Qual Life Out-comes 2020; 18(1): 378, doi: 10.1186/s12955-020-01630-7.
22. Albasara SA, Haneef MS, Zafar M, et al. Depression and associated risk factors among hypertensive patients in primary health care centers in Dammam, Kingdom of Saudi Arabia. Pan Afr Med J 2021; 38: 278, doi: 10.11604/pamj.2021.38.278.27133.
23. Ashok VG, Ghosh SS. Prevalence of Depression among Hypertensive Patients Attending a Rural Health Centre in Kanyakumari. Natl J Community Med 2019; 10(3): 172–175.
24. Iloh GUP, Aguocha GU, Amadi AN, et al. Depression among ambulatory adult patients in a primary care clinic in southeastern Nigeria. Niger Postgrad Med J 2018; 25(4): 204–212, doi: 10.4103/npmj.npmj_107_18.
25. AlKhathami AD, Alamin MA, Alqahtani AM, et al. Depression and anxiety among hypertensive and diabetic primary health care patients. Could patients’ perception of their diseases control be used as a screening tool? Saudi Med J 2017; 38(6): 621–628, doi: 10.15537/smj.2017.6.17941.
26. Ismail Z, Mohamad M, Isa MR, et al. Factors associated with anxiety among elderly hypertensive in primary care setting. J Ment Health 2015; 24(1): 29–32, doi: 10.3109/09638237.2014.971148.
27. Meng L, Chen D, Yang Y, et al. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J Hypertens 2012; 30(5): 842–851, doi: 10.1097/HJH.0b013e32835080b7.
28. Pan Y, Cai W, Cheng Q, et al. Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat 2015; 11: 1121–1130, doi: 10.2147/NDT.S77710.
29. Liu MY, Li N, Li WA, et al. Association between psychosocial stress and hypertension: a systematic review and met-analysis. Neurol Res 2017; 39(6): 573–580, doi: 10.1080/01616412.2017.1317904.
30. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37(29): 2315–2381, doi: 10.1093/eurheartj/ehw106.
31. Rubio-Guerra AF, Rodriguez-Lopez L, Vargas-Ayala G, et al. Depression increases the risk for uncontrolled hypertension. Exp Clin Cardiol 2013; 18(1): 10–12.
32. Mejia-Lancheros C, Estruch R, Martínez-González MA, et al. Blood pressure values and depression in hypertensive individuals at high cardiovascular risk. BMC Cardiovasc Disord 2014; 14: 109, doi: 10.1186/1471-2261-14-109.
33. Celik M, Yilmaz Y, Karagoz A, et al. Anxiety Disorder Associated with the COVID-19 Pandemic Causes Deterioration of Blood Pressure Control in Primary Hypertensive Patients. Medeni Med J 2021; 36(2): 83–90, doi: 10.5222/MMJ.2021.08364.
34. Kang AW, Dulin A, Nadimpalli S, et al. Stress, adherence, and blood pressure control: A baseline examination of Black women with hypertension participating in the SisterTalk II intervention. Prev Med Rep 2018; 12: 25–32, doi: 10.1016/j.pmedr.2018.08.002.
35. Dawson B, Trapp RG. Basic & clinical biostatistics. 4th ed. New York: Lange Medical Books McGraw-Hill, Medical Pub. Division; 2004.
36. Kroenke K, Spitzer RL, Williams JB. Validity of a Brief Depression Severity Measure. J Gen Intern Med 2001; 16(9): 606–613, doi: 10.1046/j.1525-1497.2001.016009606.x.
37. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166(10): 1092–1097, doi: 10.1001/archinte.166.10.1092.
38. AlHadi AN, AlAteeq DA, Al-Sharif E, et al. An Arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample. Ann Gen Psychiatry 2017; 16: 32, doi: 10.1186/s12991-017-0155-1.
39. Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapam S, Oskamp S, eds. The Social Psychology of Health. Newbury Park (CA): Sage; 1988: 31–67.
40. Chaaya M, Osman H, Naassan G, et al. Validation of the Arabic version of the Cohen Perceived Stress Scale (PSS-10) among pregnant and postpartum women. BMC Psychiatry 2010; 10: 111, doi: 10.1186/1471-244X-10-111.
41. Ali AM, Hendawy AO, Ahmad O, et al. The Arabic Version of the Cohen Perceived Stress Scale: Factorial Validity and Measurement Invariance. Brain Sci 2021; 11(4): 419, doi: 10.3390/brainsci11040419.
42. Naqvi AA, Hassali MA, Rizvi M, et al. Development and Validation of a Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in Paki-stan. Front Pharmacol 2018; 9: 1124, doi: 10.3389/fphar.2018.01124.
43. Naqvi AA, Hassali MA, Jahangir A, et al. Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses. J Drug Assess 2019; 8(1): 36–42, doi: 10.1080/21556660.2019.1579729.
44. Naqvi AA, AlShayban DM, Ghori SA, et al. Validation of the General Medication Adherence Scale in Saudi Patients with Chronic Diseases. Front Pharmacol 2019; 10: 633, doi: 10.3389/fphar.2019.00633.
45. Naqvi AA, Mahmoud MA, AlShayban DM, et al. Translation and validation of the Arabic version of the General Medication Adherence Scale (GMAS) in Saudi patients with chronic illnesses. Saudi Pharm J 2020; 28(9): 1055–1061, doi: 10.1016/j.jsps.2020.07.005.
46. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hyper-tension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36(10): 1953–2041, doi: 10.1097/HJH.0000000000001940.
47. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension 2020; 75(6): 1334–1357, doi: 10.1097/HJH.0000000000002453
48. Al-Qahtani AM. Prevalence and determinants of blood pressure control among hypertensive patients in primary care centers, Najran, Saudi Arabia. Biomed Pharmacol J 2018; 11(2): 821–825.
49. Teshome DF, Demssie AF, Zeleke BM. Determinants of blood pressure control amongst hypertensive patients in Northwest Ethiopia. PLoS ONE 2018; 13(5): e0196535, doi: 10.1371/journal.pone.0196535.
50. Tapela N, Collister J, Clifton L, et al. Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK. Open Heart 2021; 8(1): e001461, doi: 10.1136/openhrt-2020-001461.
51. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310(9): 959–968, doi: 10.1001/jama.2013.184182.
52. Picone DS, Schultz MG, Otahal P, et al. Influence of age on upper arm cuff blood pressure measurement. Hypertension 2020; 75(3): 844–850, doi: 10.1161/HYPERTENSIONAHA.119.13973.
53. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71(19): e127–e248, doi: 10.1016/j.jacc.2017.11.006.
54. MacDonald TM, Williams B, Webb DJ, et al. Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: a double-blind randomized controlled trial. J Am Heart Assoc 2017; 6(11): e006986, doi: 10.1161/JAHA.117.006986.
55. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55(2): 399–407, doi: 10.1161/HYPERTENSIONAHA.109.139816.
56. Abegaz TM, Shehab A, Gebreyohannes EA, et al. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine (Baltimore) 2017; 96(4): e5641, doi: 10.1097/MD.0000000000005641.
57. Corrêa NB, de Faria AP, Ritter AM, et al. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension. J Am Soc Hypertens 2016; 10(6): 510–516, doi: 10.1016/j.jash.2016.03.194.
58. Li J, Zhang Z, Si S, et al. Antihypertensive medication adherence and cardiovascular disease risk: a longitudinal cohort study. Atherosclerosis 2021; 320: 24–30, doi: 10.1016/j.atherosclerosis.2021.01.005.
59. Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med 2017; 99: 269–276, doi: 10.1016/j.ypmed.2017.03.008.
60. Khatib R, Schwalm JD, Yusuf S, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS ONE 2014; 9(1): e84238, doi: 10.1371/journal.pone.0084238.
61. Pan Y, Cai W, Cheng Q, et al. Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neurosci Biobehav Rev 2021; 131: 96–119, doi: 10.1016/j.neubiorev.2021.08.031.
62. Kayano H, Koba S, Matsui T, et al. Anxiety Disorder Is Associated with Nocturnal and Early Morning Hypertension with or Without Morning Surge – Ambulatory Blood Pressure Monitoring. Circ J 2012; 76(7): 1670–1677, doi: 10.1253/circj.cj-11-1085.
63. Grossman E, Nadler M, Sharabi Y, et al. Antianxiety treatment in patients with excessive hypertension. American J Hypertens 2005; 18(9): 1174–1177.
64. Polyák J. How should we manage cardiovascular panic disorder accompanied by hypertension. J Hypertens 2001; 19(Suppl. 2): S64.
65. Brook RD, Appel LJ, Rubenfire M, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association. Hypertension 2013; 61(6): 1360–1383.
66. Rubio-Guerra AF, Rodriguez-Lopez L, Vargas-Ayala G, et al. Depression increases the risk for uncontrolled hypertension. Exp Clin Cardiol 2013; 18(1): 10–12.
67. Wiehe M, Fuchs SC, Moreira LB, et al. Absence of association between depression and hypertension: results of a prospectively designed population-based study. J Hum Hypertens 2006; 20(6): 434–439, doi: 10.1038/sj.jhh.1002017.
68. Diminic-Lisica I, Popovic B, Rebic J, et al. Outcome of treatment with antidepressants in patients with hypertension and undetected depression. Int J Psychiatry Med 2014; 47(2): 115–129, doi: 10.2190/PM.47.2.c.
69. Breeden M, Gillis A, Salas J, et al. Antidepressant treatment and blood pressure control in patients with comorbid depression and treatment resistant hyper-tension. J Psychosom Res 2022; 153: 110692, doi: 10.1016/j.jpsychores.2021.110692.
70. Lu X, Juon HS, He X, et al. The association between perceived stress and hypertension among Asian Americans: does social support and social network make a difference? J Community Health 2019; 44(3): 451–462, doi: 10.1007/s10900-018-00612-7.
71. Logan JG, Barksdale DJ, Carlson J, et al. Psychological stress and arterial stiffness in Korean Americans. J Psychosom Res 2012; 73(1): 53–58, doi: 10.1016/j.jpsychores.2012.04.008.
72. Miguet M, Olivo G, Ciuculete DM, et al. Perceived stress is related to lower blood pressure in a Swedish cohort. Scand J Public Health 2021: 14034948211030352, doi: 10.1177/14034948211030352.
73. Ahmadpanah M, Paghale SJ, Bakhtyari A, et al. Effects of psychotherapy in combination with pharmacotherapy, when compared to pharmacotherapy only on blood pressure, depression, and anxiety in female patients with hypertension. J Health Psychol 2016; 21(7): 1216–1227, doi: 10.1177/1359105314550350.
Copyright: © 2023 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.